e.g. Tata motors, Reliance MF, 500570

Kabra Drugs Ltd.

524322  KABRADG   Group (X)

22 Apr,11:33
26.81 -0.02 (-0.07%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
BSE  |  NSE
zoomZoomRefresh
Day
Wk
Mn
6Mn
Yr
Volume

19,141

Prev close

26.83

Day's H/L (Rs.)

27.45 - 26.80

52wk H/L (Rs.)

35.52 - 10.56

Mkt Cap (Rs. Cr)

63.54

Kabra Drugs Ltd.

InvestChart

Kabra Drugs Ltd. is not listed on NSE (View BSE)

Financial Results of Kabra Drugs Ltd.

(Rs. Crore)
Mar ' 25Mar ' 24Mar ' 23Mar ' 22Mar ' 21
Sales-----
Operating profit-1.72-0.74-0.34-0.18-0.15
Interest-----
Gross profit-1.08-0.74-0.34-0.18-0.15
EPS (Rs)-0.46-1.68-0.77-0.42-0.41

See More >

Compare 'Kabra Drugs Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,668.00
  • Compare
  • Divi's Laboratories Ltd.
  • 6,281.35
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 1,232.25
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 4,188.15
  • Compare
  • Zydus Lifesciences Ltd.
  • 936.35
  • Compare
  • Max Healthcare Institute Ltd.
  • 1,010.35
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 7,653.85
  • Compare

Statements:

Balance Sheet  |  P&L  |  Cash Flow  |  Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Kabra Drugs Ltd. PERFORMANCE SNAPSHOT

If you had invested Rs.
in Kabra Drugs Ltd.,
  ago

You would have Rs. 000.00

Add to Portfolio

Report Card

PE Ratios
-59.32
EPS (Rs.)
-0.46
Sales (Rs. Cr)
30.42
Face Value (Rs.)
10
Net Profit Margin (%)
Last Bonus
Last Dividend (%)
Return on Average Equity
-4.4

Frequently Asked Questions

Q: What is the current share price of Kabra Drugs Ltd.?

A: The current share price of Kabra Drugs Ltd. is ₹ 26.81 (for BSE as on 22 Apr,11:33). The 52-week range is ₹ 35.52 - 10.56. Prices are updated based on live market data.

Q: What is the market capitalization of Kabra Drugs Ltd.?

A: Kabra Drugs Ltd. has a market capitalization of ₹ 63.54 Cr, making it a company.

Q: What is the PE ratio of Kabra Drugs Ltd.?

A: The Price-to-Earnings (PE) ratio of Kabra Drugs Ltd. is -59.32, indicating its valuation relative to earnings.

Q: Is Kabra Drugs Ltd. a good investment?

A: Kabra Drugs Ltd. is considered based on its financial performance, sector outlook, and market conditions. Investors should evaluate fundamentals and consult financial advisors before investing.

Q: What are the latest financial results of Kabra Drugs Ltd.?

A: Kabra Drugs Ltd. has reported its latest annual results with revenue of ₹ - and net profit/loss of ₹ -1.09.

Close
Add Kabra Drugs Ltd. to your Portfolio
 
 
     
 
Close
Add Kabra Drugs Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback